163
Views
7
CrossRef citations to date
0
Altmetric
Pharmacoeconomics Evaluation

Pharmacoeconomics of voriconazole

&
Pages 877-887 | Published online: 05 Mar 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Stuart J Turner, Sharon CA Chen, Monica A Slavin & David CM Kong. (2013) Pharmacoeconomics of empirical antifungal use in febrile neutropenic hematological malignancy and hematopoietic stem cell transplant patients. Expert Review of Pharmacoeconomics & Outcomes Research 13:2, pages 227-235.
Read now

Articles from other publishers (6)

Georg Auzinger, E. Geoffrey Playford, Christopher N. Graham, Hediyyih N. Knox, David Weinstein, Michal Kantecki, Haran Schlamm & Claudie Charbonneau. (2015) Cost-effectiveness analysis of anidulafungin for the treatment of candidaemia and other forms of invasive candidiasis. BMC Infectious Diseases 15:1.
Crossref
Helmut Ostermann, Carlos Solano, Isidro Jarque, Carolina Garcia-Vidal, Xin Gao, Jon Andoni Barrueta, Marina De Salas-Cansado, Jennifer Stephens, Mei Xue, Bertram Weber & Claudie Charbonneau. (2014) Cost analysis of voriconazole versus liposomal amphotericin B for primary therapy of invasive aspergillosis among patients with haematological disorders in Germany and Spain. BMC Pharmacology and Toxicology 15:1.
Crossref
Nina L. Tuite & Katrina Lacey. 2013. Fungal Diagnostics. Fungal Diagnostics 1 23 .
Yong-Li Zhong, Donald R. GauthierJr.Jr., Yao-Jun Shi, Mark McLaughlin, John Y. L. Chung, Philippe Dagneau, Benjamin Marcune, Shane W. Krska, Richard G. Ball, Robert A. Reamer & Nobuyoshi Yasuda. (2012) Synthesis of Antifungal Glucan Synthase Inhibitors from Enfumafungin. The Journal of Organic Chemistry 77:7, pages 3297-3310.
Crossref
Javier Soto ÁlvarezJavier Soto Álvarez. 2012. Evaluación económica de medicamentos y tecnologías sanitarias:. Evaluación económica de medicamentos y tecnologías sanitarias: 277 292 .
C. Wintenberger. (2011) Prise en charge et prophylaxie des infections fongiques invasives en hématologie. Médecine et Maladies Infectieuses 41:9, pages 503-507.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.